ZA201903749B - Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome - Google Patents
Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndromeInfo
- Publication number
- ZA201903749B ZA201903749B ZA2019/03749A ZA201903749A ZA201903749B ZA 201903749 B ZA201903749 B ZA 201903749B ZA 2019/03749 A ZA2019/03749 A ZA 2019/03749A ZA 201903749 A ZA201903749 A ZA 201903749A ZA 201903749 B ZA201903749 B ZA 201903749B
- Authority
- ZA
- South Africa
- Prior art keywords
- alleviating
- preventing
- carbamate compound
- tremor syndrome
- treating tremors
- Prior art date
Links
- 206010044565 Tremor Diseases 0.000 title 2
- -1 carbamate compound Chemical class 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160170225 | 2016-12-14 | ||
| PCT/KR2017/014743 WO2018111009A1 (ko) | 2016-12-14 | 2017-12-14 | 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201903749B true ZA201903749B (en) | 2022-01-26 |
Family
ID=62558966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2019/03749A ZA201903749B (en) | 2016-12-14 | 2019-06-11 | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11033531B2 (enExample) |
| EP (1) | EP3556364B1 (enExample) |
| JP (1) | JP7086076B2 (enExample) |
| KR (1) | KR102635941B1 (enExample) |
| CN (1) | CN110267657B (enExample) |
| AU (1) | AU2017374459B2 (enExample) |
| CA (1) | CA3046300A1 (enExample) |
| CL (1) | CL2019001623A1 (enExample) |
| ES (1) | ES3039979T3 (enExample) |
| IL (1) | IL267191B2 (enExample) |
| MX (1) | MX391363B (enExample) |
| MY (1) | MY198417A (enExample) |
| WO (1) | WO2018111009A1 (enExample) |
| ZA (1) | ZA201903749B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019098626A1 (ko) * | 2017-11-14 | 2019-05-23 | 에스케이바이오팜 주식회사 | 후기 나트륨 전류의 증가와 관련된 질환을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
| JP7408643B2 (ja) * | 2018-09-21 | 2024-01-05 | エスケー バイオファーマスティカルズ カンパニー リミテッド | カルバメート化合物及びそれを含む製剤の急性ストレス障害又は心的外傷後ストレス障害の予防、軽減又は治療のための使用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004527492A (ja) * | 2001-02-27 | 2004-09-09 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 運動障害の予防もしくは治療における使用のためのカルバメート化合物 |
| JP2007530694A (ja) | 2004-03-29 | 2007-11-01 | メルク エンド カムパニー インコーポレーテッド | ナトリウムチャネル遮断薬としてのビアリール置換ピラジノン |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| CN101657194B (zh) * | 2007-03-05 | 2013-10-23 | Indus生物技术私人有限公司 | 包含葫芦巴碱和4-羟基异亮氨酸的药物组合物及其方法 |
| CN102803233B (zh) * | 2009-06-22 | 2017-03-01 | 爱思开生物制药株式会社 | 制备氨基甲酸(r)‑1‑芳基‑2‑四唑基‑乙酯的方法 |
| US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| ES2998534T3 (en) * | 2013-03-12 | 2025-02-20 | Bio Pharm Solutions Co Ltd | Phenyl carbamate compounds for use in preventing or treating pediatric epilesy |
| KR102489052B1 (ko) * | 2016-05-19 | 2023-01-16 | 에스케이바이오팜 주식회사 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
-
2017
- 2017-12-14 KR KR1020197018409A patent/KR102635941B1/ko active Active
- 2017-12-14 WO PCT/KR2017/014743 patent/WO2018111009A1/ko not_active Ceased
- 2017-12-14 ES ES17880232T patent/ES3039979T3/es active Active
- 2017-12-14 MY MYPI2019003351A patent/MY198417A/en unknown
- 2017-12-14 CA CA3046300A patent/CA3046300A1/en active Pending
- 2017-12-14 JP JP2019531817A patent/JP7086076B2/ja active Active
- 2017-12-14 CN CN201780077642.3A patent/CN110267657B/zh active Active
- 2017-12-14 MX MX2019006941A patent/MX391363B/es unknown
- 2017-12-14 US US16/468,936 patent/US11033531B2/en active Active
- 2017-12-14 AU AU2017374459A patent/AU2017374459B2/en active Active
- 2017-12-14 EP EP17880232.8A patent/EP3556364B1/en active Active
-
2019
- 2019-06-10 IL IL267191A patent/IL267191B2/en unknown
- 2019-06-11 ZA ZA2019/03749A patent/ZA201903749B/en unknown
- 2019-06-12 CL CL2019001623A patent/CL2019001623A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX391363B (es) | 2025-03-21 |
| IL267191A (enExample) | 2019-07-31 |
| MX2019006941A (es) | 2019-09-06 |
| WO2018111009A1 (ko) | 2018-06-21 |
| JP7086076B2 (ja) | 2022-06-17 |
| CA3046300A1 (en) | 2018-06-21 |
| CN110267657A (zh) | 2019-09-20 |
| RU2019121914A3 (enExample) | 2021-04-21 |
| IL267191B2 (en) | 2023-05-01 |
| KR102635941B1 (ko) | 2024-02-13 |
| KR20190087573A (ko) | 2019-07-24 |
| EP3556364A4 (en) | 2020-06-17 |
| US20190336481A1 (en) | 2019-11-07 |
| JP2020502137A (ja) | 2020-01-23 |
| AU2017374459A1 (en) | 2019-07-04 |
| CL2019001623A1 (es) | 2019-08-23 |
| MY198417A (en) | 2023-08-29 |
| US11033531B2 (en) | 2021-06-15 |
| RU2019121914A (ru) | 2021-01-15 |
| CN110267657B (zh) | 2022-12-13 |
| EP3556364B1 (en) | 2025-08-27 |
| ES3039979T3 (en) | 2025-10-28 |
| IL267191B1 (en) | 2023-01-01 |
| EP3556364A1 (en) | 2019-10-23 |
| AU2017374459B2 (en) | 2023-04-27 |
| BR112019012000A2 (pt) | 2019-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264049A (en) | Compounds, preparations and methods for treating the disease | |
| DK3658539T3 (da) | Forbindelser og sammensætninger til behandling af tilstande, som er forbundet med nlrp-aktivitet | |
| IL264156A (en) | Compounds, preparations and methods for treating the disease | |
| ZA201708039B (en) | Adenoassociated virus vectors for the treatment of mucopolysaccharidoses | |
| SI3109223T1 (sl) | Zmes za obdelavo gnojil, ki vsebujejo sečnino | |
| WO2014165090A8 (en) | Compounds for the treatment of tuberculosis | |
| DK3624796T3 (da) | Pyrrolopyridin.anilinforbindelser til behandling af hudlidelse | |
| PL3065732T3 (pl) | Związki, kompozycje i odpowiednie zastosowania do zapobiegania i/lub leczenia dyslipidemii | |
| PT3519569T (pt) | Vetores de vírus adenoassociados para o tratamento de mucopolissacaridoses | |
| IL262825A (en) | Tetrahydropyridine and tetrahydropyrimidine substances, preparations containing them and their use for pain treatment | |
| PL3384915T3 (pl) | Karymycyna do leczenia zakażeń prątkiem gruźlicy | |
| PL3459543T3 (pl) | Związek karbaminianowy do zapobiegania lub leczenia fibromialgii | |
| ZA201906047B (en) | Compounds for treating tuberculosis | |
| IL251456A0 (en) | Substances with agonist activity for gpr119, processes for their preparation and preparations containing them | |
| EP2982378A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK WITH ADK PROTEIN AS AN ACTIVE SUBSTANCE | |
| ZA201903749B (en) | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome | |
| ZA201903747B (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| IL274428A (en) | Use of a carbamate compound to prevent, relieve or treat a withdrawal seizure or epilepsy presenting with a withdrawal seizure | |
| PL3459542T3 (pl) | Zastosowanie związku karbaminianu do zapobiegania lub leczenia neuralgii nerwu trójdzielnego | |
| IL274084A (en) | Comb for the treatment of dandruff | |
| ZA201901948B (en) | Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections | |
| GB201614609D0 (en) | Compounds for treatment of intractable epilepsy and doors syndrome | |
| GB201701928D0 (en) | Compounds for the treatment of hyperglycaemia | |
| GB201603882D0 (en) | Compounds for the treatment of type 2 diabetes | |
| GB201603886D0 (en) | Compounds for the treatment of type 2 diabetes |